Assembly Biosciences, Inc. revenue breakdown overview

Assembly Biosciences, Inc. revenue for the last year amounted to 28.52 M USD, the most of which — 28.52 M USD — came from its highest performing source at the moment, Innovative Therapeutics Targeting Serious Viral Diseases, the year earlier bringing 7.16 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Assembly Biosciences, Inc. 28.52 M USD, and the year before that — 7.16 M USD.